DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Thatcher N, Hirsch FR, Luft AV. et al.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Lancet Oncol 2015;
16: 763-774
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.